|
|
▲ Dealers working on the 3rd. Yonhap News |
[에너지경제신문 온라인뉴스팀] On the 3rd, the Financial Services Commission announced that it will resume short selling of constituents in the KOSDAQ 150 and KOSPI 200 indexes from May 3, attracting attention. For the remaining 2037 stocks, the ban on short selling will be extended without a separate deadline.
Short selling is an investment technique that borrows and sells stocks when stock prices are expected to decline, and then buys and repays stocks when the stock price goes down.
The Financial Services Commission banned it for six months after the stock market crashed due to the corona 19 incident in March last year. Short selling has since been extended for six months due to the Corona 19 situation.
The Financial Services Commission said, “The members agreed that it is inevitable to resume short selling given the current situation in the domestic stock market, the resumption of short selling in other countries, and the international status of the domestic stock market.” “We gathered opinions that we should induce a soft landing by partially reopening,” he said.
The Financial Services Commission explained that the KOSDAQ 150 and KOSPI 200 constituents, which are subject to reopening, have considered the limited impact of short selling on prices due to their large market cap and abundant liquidity.
KOSDAQ 150 yen Celltrion Healthcare selected as the grand prize. Celltrion Pharmaceuticals, HLB, Seegen, Pearl Abyss, Ecopro BM, Alteogen, Kakao Games, CJ ENM, and SK Materials.
Samsung Electronics, SK Hynix, LG Chem, NAVER, Samsung Biologics, Hyundai Motors, Samsung SDI, Celltrion, Kakao, and Kia Motors are representative of the KOSPI 200 stocks.